Cubresa’s NuPET Bio
Small Animal PET scanner and animal handling system specifically designed for high containment labs
Cubresa’s NuPET Bio is the world’s first lightweight preclinical PET scanner, specially designed for use with highly infectious pathogens. The device will allow researchers to conduct work on SARS-CoV-2, and other viruses and bacteria, directly in BSL-3 labs without the need for extensive retrofits of the lab space, saving researchers and institutions valuable time and money.
Incorporation of the NuPET Bio into this preclinical work will enable researchers to study the pathogenesis of viruses, as well as understand how prospective antivirals and vaccines affect the physiology of the body, their toxicity, and their effectiveness at fighting/preventing diseases.
NuPET Bio PET scanners are available for small and large animal imaging. Please contact Cubresa to learn more.
Perron JR, McIntosh BJ, Leggett S, Palmer VL, Herrera SL, Armstrong K, Stecina K, Martin M. Multi-modal PET-MR imaging of the selective activation of serotonergic neurons in living rodent brains with DREADD technology. Manitoba Poster Competition, Canadian Student Health Research Forum, August 21, 2020. https://umanitoba.ca/outreach/conferences/research_days/dates_info.html
Van Elburg D, Shrestha R, and Goertzen AL. Towards a second-generation PET/MR insert with enhanced timing and count rate performance. Physics in Medicine and Biology. 2019 Mar 12. doi: https://doi.org/10.1088/1361-6560/ab0efa
PET/MRI evaluation of white matter inflammation in a co-morbid rat model of ischemic stroke and Alzheimer’s disease (and others)
Jonathan Thiessen, Ph.D., Director, PET/MRI Program, Lawson Health Research Institute, Assistant Professor, Depts. of Medical Biophysics and Medical Imaging, Western University.
Matthew S. Fox, Ph.D., Preclinical Imaging Physicist, Lawson Health Research Institute Research Associate, Dept. of Physics and Astronomy, Western University By helping to advance hybrid PET/MRI and multi-parametric diagnostic imaging tools, we hope to give new insight into the early biomarkers of disease and improve diagnosis and therapy in patients. Projects at a glance: PET/MRI…